Ventas (VTR) to Release Quarterly Earnings on Monday
by Jessica Moore · The Cerbat GemVentas (NYSE:VTR – Get Free Report) is anticipated to issue its Q1 2026 results after the market closes on Monday, April 27th. Analysts expect the company to announce earnings of $0.1229 per share and revenue of $1.5786 billion for the quarter. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Parties may review the information on the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Tuesday, April 28, 2026 at 10:00 AM ET.
Ventas (NYSE:VTR – Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.81 earnings per share. On average, analysts expect Ventas to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Ventas Trading Up 1.0%
Shares of NYSE:VTR opened at $83.75 on Friday. The stock has a market capitalization of $39.82 billion, a PE ratio of 155.09, a P/E/G ratio of 2.04 and a beta of 0.75. Ventas has a 1 year low of $61.76 and a 1 year high of $88.36. The firm has a fifty day moving average price of $84.70 and a 200 day moving average price of $79.58. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03.
Ventas Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were issued a $0.52 dividend. This is a boost from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Tuesday, March 31st. Ventas’s dividend payout ratio is currently 385.19%.
Insider Activity
In related news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares of the company’s stock, valued at $6,184,175. This trade represents a 32.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.53% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the business. Wiser Advisor Group LLC acquired a new position in Ventas in the third quarter worth about $27,000. IFC & Insurance Marketing Inc. acquired a new position in Ventas in the fourth quarter worth about $30,000. Zions Bancorporation National Association UT raised its position in Ventas by 250.3% in the fourth quarter. Zions Bancorporation National Association UT now owns 508 shares of the real estate investment trust’s stock worth $39,000 after purchasing an additional 363 shares in the last quarter. DV Equities LLC acquired a new position in Ventas in the fourth quarter worth about $51,000. Finally, Rossby Financial LCC raised its position in Ventas by 45.8% in the fourth quarter. Rossby Financial LCC now owns 729 shares of the real estate investment trust’s stock worth $56,000 after purchasing an additional 229 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the stock. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. JPMorgan Chase & Co. raised their target price on shares of Ventas from $88.00 to $93.00 and gave the company an “overweight” rating in a research note on Friday, March 20th. KeyCorp raised their target price on shares of Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Morgan Stanley set a $90.00 price target on shares of Ventas in a report on Friday, February 13th. Finally, Argus set a $88.00 price target on shares of Ventas in a report on Tuesday, February 10th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Ventas currently has an average rating of “Moderate Buy” and an average target price of $90.47.
View Our Latest Stock Analysis on VTR
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.